2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …
K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
European heart journal, 2022•academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only
after the patient has been informed and has provided consent;(2) country-specific health
regulations, indications by governmental drug regulatory agencies, and the ethical rules to
which health professionals are subject, where applicable.
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only
after the patient has been informed and has provided consent;(2) country-specific health
regulations, indications by governmental drug regulatory agencies, and the ethical rules to
which health professionals are subject, where applicable.
4004 ESC Guidelines label use of medication should be limited to situations where it is in the patient’s interest to do so, with regard to the quality, safety, and efficacy of care, and only after the patient has been informed and has provided consent;(2) country-specific health regulations, indications by governmental drug regulatory agencies, and the ethical rules to which health professionals are subject, where applicable.
Oxford University Press以上显示的是最相近的搜索结果。 查看全部搜索结果